Last reviewed · How we verify

NCT06098092: BPLONG

Long-term Accuracy and Stability of Blood Pressure Measurements From a Smartwatch: Prospective Validation Study

Completed NA Last updated 12 March 2026
What this trial tests

NA trial testing Long-term non-invasive Blood pressure monitoring in Hypertension in 42 participants. Completed in 1 November 2025.

Timeline
13 October 2023
Primary endpoint
30 October 2025
1 November 2025

Quick facts

Lead sponsorCzech Technical University in Prague
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment42
Start date13 October 2023
Primary completion30 October 2025
Estimated completion1 November 2025
Sites2 locations across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Czech Technical University in Prague

Who can join

22 and older, any sex, with Hypertension or Blood Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to perform an experimental validation of the long-term accuracy of blood pressure measurement using the Samsung Galaxy Smartwatch

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Long-term accuracy and stability of blood pressure measurements from a smartwatch: Prospective validation study.
    Walzel S, Sebestova H, Rafl-Huttova V, Rozanek M, et al · · 2026 · PMID 41602947 · DOI 10.1177/20552076261415923

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Czech Technical University in Prague trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06098092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing